MedPath

Investigating the effect of empagliflozin in heart failure in HIV patients

Phase 3
Recruiting
Conditions
Heart failure with low output in HIV positive patient.
Heart failure, unspecified
150.9
Registration Number
IRCT20130719014054N2
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
128
Inclusion Criteria

Age >18YEARS
HIV
EF<50%

Exclusion Criteria

MALIGNANCY OR Opportunistic infection
PREGNANCY
CKD AND GFR<20

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath